1-7 of 7
Madhusmita Behera
Close
Sort by
Journal Articles

Insurance Status Impacts Survival in Burkitt Lymphoma

Jordan S. Goldstein, BS, Jeffrey M. Switchenko, PhD MS, Madhusmita Behera, PhD, Christopher Flowers, MD, Jean L. Koff, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 916.
https://doi.org/10.1182/blood.V130.Suppl_1.916.916
Published: 2017
Journal Articles

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma

CME Clinical Trials & Observations
Richard J. Lin, Madhusmita Behera, Catherine S. Diefenbach, Christopher R. Flowers
Journal: Blood
Blood (2017) 130 (20): 2180–2185.
https://doi.org/10.1182/blood-2017-05-736975
Published: 2017
Journal Articles

Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma

Clinical Trials & Observations
Jonathon B. Cohen, Madhusmita Behera, Carrie A. Thompson, Christopher R. Flowers
Journal: Blood
Blood (2017) 129 (5): 561–564.
https://doi.org/10.1182/blood-2016-08-685073
Published: 2017
Journal Articles

Efficacy and Safety of Triplet Versus Doublet Salvage Therapies Among Patients with Multiple Myeloma (MM) Experiencing Early Relapse: Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)

Ajay K. Nooka, MD MPH, Jonathan L. Kaufman, MD, Madhusmita Behera, PhD, Charise Gleason, MSN, ANP-BC, AOCNP, Hannah Collins, ANP-BC, OCN, Vikas A. Gupta, MD PhD, Lawrence H Boise, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2015) 126 (23): 5344.
https://doi.org/10.1182/blood.V126.23.5344.5344
Published: 2015
Journal Articles

The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs),

Ajay K. Nooka, MD, MPH, FACP, Jonathan L. Kaufman, MD, Madhusmita Behera, Charise Gleason, Amelia Langston, MD, Conor Ermst Steuer, MD, Christopher R Flowers, MD, Lawrence H. Boise, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2011) 118 (21): 3994.
https://doi.org/10.1182/blood.V118.21.3994.3994
Published: 2011
Journal Articles

Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis

Ajay K. Nooka, MD, MPH, FACP, Madhusmita Behera, Lawrence H. Boise, PhD, Melanie Watson, Jonathan L. Kaufman, MD, Sagar Lonial, MD
Journal: Blood
Blood (2011) 118 (21): 1855.
https://doi.org/10.1182/blood.V118.21.1855.1855
Published: 2011
Journal Articles

Role of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review and Meta-Analysis.

Madhusmita Behera, MS, Ambuj Kumar, MD, MPH, Mohamed A. Kharfan-Dabaja, MD, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2872.
https://doi.org/10.1182/blood.V110.11.2872.2872
Published: 2007